| Literature DB >> 31824929 |
Maike Otto1, Benedikt Wynands1, Christoph Lenzen2, Melanie Filbig2, Lars M Blank2, Nick Wierckx1.
Abstract
Microbial biocatalysis represents a promising alternative for the production of a variety of aromatic chemicals, where microorganisms are engineered to convert a renewable feedstock under mild production conditions into a valuable chemical building block. This study describes the rational engineering of the solvent-tolerant bacterium Pseudomonas taiwanensis VLB120 toward accumulation of L-phenylalanine and its conversion into the chemical building block t-cinnamate. We recently reported rational engineering of Pseudomonas toward L-tyrosine accumulation by the insertion of genetic modifications that allow both enhanced flux and prevent aromatics degradation. Building on this knowledge, three genes encoding for enzymes involved in the degradation of L-phenylalanine were deleted to allow accumulation of 2.6 mM of L-phenylalanine from 20 mM glucose. The amino acid was subsequently converted into the aromatic model compound t-cinnamate by the expression of a phenylalanine ammonia-lyase (PAL) from Arabidopsis thaliana. The engineered strains produced t-cinnamate with yields of 23 and 39% Cmol Cmol-1 from glucose and glycerol, respectively. Yields were improved up to 48% Cmol Cmol-1 from glycerol when two enzymes involved in the shikimate pathway were additionally overexpressed, however with negative impact on strain performance and reproducibility. Production titers were increased in fed-batch fermentations, in which 33.5 mM t-cinnamate were produced solely from glycerol, in a mineral medium without additional complex supplements. The aspect of product toxicity was targeted by the utilization of a streamlined, genome-reduced strain, which improves upon the already high tolerance of P. taiwanensis VLB120 toward t-cinnamate.Entities:
Keywords: L-phenylalanine; Pseudomonas; glucose; glycerol; metabolic engineering; rational engineering; trans-cinnamic acid
Year: 2019 PMID: 31824929 PMCID: PMC6882275 DOI: 10.3389/fbioe.2019.00312
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Plasmids.
| pEMG | KmR, oriR6K, lacZα with two flanking I-SceI sites | Martínez-García and de Lorenzo, |
| pSW-2 | GmR, oriRK2, | Martínez-García and de Lorenzo, |
| pEMG- | pEMG bearing flanking sequences of | Wynands et al., |
| pEMG- | pEMG bearing flanking sequences of | Wynands et al., |
| pEMG- | pEMG bearing flanking sequences of | Wynands et al., |
| pEMG- | pEMG bearing flanking sequences of | Wynands et al., |
| pEMGu-PVLB_13075 | pEMGu bearing flanking sequences of | Wynands et al., |
| pEMG- | pEMG bearing flanking sequences of | Wynands et al., |
| pEMGu- | pEMGu bearing flanking sequences of | Wynands et al., |
| pEMGg- | pEMGg bearing flanking sequences of | Wynands et al., |
| pEMGg- | pEMGg bearing flanking sequences of | Wynands et al., |
| pEMG- | pEMG bearing flanking sequences of | This study |
| pEMG- | pEMG bearing flanking sequences of | This study |
| pEMG-PVLB_10925 | pEMG bearing flanking sequences of PVLB_10925, PVLB_10925 deletion delivery vector | This study |
| pBG14d- | KmR GmR, ori R6K, Tn7L and Tn7R extremes, P | Zobel et al., |
| pBG14f- | KmR GmR, ori R6K, Tn7L and Tn7R extremes, P14f-BCD2– | Zobel et al., |
| pBG14g- | KmR GmR, ori R6K, Tn7L and Tn7R extremes, P14g-BCD2– | Zobel et al., |
| pBG14d-a | KmR GmR, ori R6K, Tn7L and Tn7R extremes, P | This study |
| pBG14g | KmR GmR, ori R6K, Tn7L and Tn7R extremes, P14g-BCD2–a | This study |
| pBG14f- | KmR GmR, ori R6K, Tn7L and Tn7R extremes, P14f-BCD2–At-PAL fusion, | This study |
Bacterial strains.
| DH5α λpir | de Lorenzo and Timmis, | |
| PIR2 | Invitrogen | |
| HB101 pRK2013 | Boyer and Roulland-Dussoix, | |
| DH5α λpir pTNS1 | DH5α λpir bearing plasmid pTNS1 | de Lorenzo Lab |
| VLB120 | Wildtype | Panke et al., |
| VLB120ΔpSTY | ΔpSTY | Wynands et al., |
| GRC1 | ΔpSTY, Δprophage1/2, Δprophage3, Δprophage4, Δflag1, Δflag2, Δlap1, Δlap2, Δlap3 | Wynands et al., |
| GRC2 | ΔpSTY, Δprophage1/2:: | Wynands et al., |
| GRC3 | ΔpSTY, Δprophage1/2:: | Wynands et al., |
| GRC3 Δ5Δ | GRC3 with Δ | Wynands, |
| GRC3 Δ5Δ | GRC3 Δ5Δ | This study |
| GRC3 Δ5Δ | GRC3 Δ5Δ | This study |
| GRC3 Δ5Δ | GRC3 Δ5Δ | This study |
| GRC3 Δ8Δ | GRC3 Δ5Δ | This study |
| GRC3 Δ8Δ | GRC3 Δ8Δ | This study |
| GRC3 Δ8Δ | GRC3 Δ8Δ | This study |
| GRC3 Δ5Δ | GRC3 Δ5Δ | This study |
| GRC3 Δ5Δ | GRC3 Δ5Δ | This study |
| GRC3 Δ5Δ | GRC3 Δ5Δ | This study |
| GRC3 Δ5Δ | GRC3 Δ5Δ | This study |
| GRC3 Δ8Δ | GRC3 Δ5Δ | This study |
Figure 3L-phenylalanine and L-tyrosine accumulation of P. taiwanensis GRC3 Δ5ΔpykA-tap and subsequent mutants with deletions to prevent L-phenylalanine degradation and additional overexpression of AroGfbr and PheAT310I. The strains were cultivated in MSM containing 20 mM glucose in a System Duetz® shaker. Error bars represent the standard error of the mean (n = 3).
Figure 1Enhanced growth of genome-reduced Pseudomonas taiwanensis chassis strains in the presence of t-cinnamate. (A) Growth of the P. taiwanensis VLB120 wildtype and the three genome-reduced chassis strains in the presence of 30 mM of t-cinnamate in mineral salts medium (MSM) containing 20 mM of glucose. (B) Growth of P. taiwanensis GRC3 at increasing t-cinnamate concentrations (0–50 mM) in MSM. Growth was monitored in the Growth Profiler®, error bars represent the standard error of the mean (n = 3).
Figure 2Genomic modifications introduced into strain P. taiwanensis GRC3 to enable accumulation of L-phenylalanine and subsequent deamination to t-cinnamate. Red arrows and annotations indicate gene deletions, purple arrows represent enzymatic downregulation, green annotations highlight point mutations introduced into the native gene locus, and blue tags and arrows represent the overexpression of heterologous genes. DAHP, dihydroxyacetone phosphate; KDPG, 2-keto-3-deoxy-6-phosphogluconate; F6P, fructose-6-phosphate; G3P, glyceraldehyde-3-phosphate; 3PG, 3-phosphoglycerat; S7P, seduheptulose-7-phosphate; PEP, phosphoenolpyruvate; PYR, pyruvate; E4P, erythrose-4-phosphate; DAHP, 3-deoxy-D-arabinoheptulosonate-7-phosphate; DHQ, 3-dehydroquinate; DHS, 3-dehydroshikimate; SA, shikimate; S3P, shikimate-3-phosphate; EPSP, 5-enolpyruvyl-shikimate-5-phosphate; CHO, chorismate; 4-HB, 4-hydroxybenzoate; PCA, protocatechuate; ANT, anthranilate; TRP, tryptophan; PRE, prephenate; PP, phenylpyruvate; HPP, 4-hydroxyphenylpyruvate; ARO, arogenate; TYR, tyrosine; PHE, phenylalanine; HMG, homogentisate; PAA, 2-phenylacetamide; PEA, phenylethylamine; PykA/PykF, pyruvate kinase isozymes; QuiC/QuiC1/QuiC2, 3-dehydroshikimate dehydratase isozymes; PobA, 4-hydroxybenzoate 3-monooxygenase; Hpd, 4-hydroxyphenylpyruvate dioxygenase; AroF-1P148L/AroGfbr, DAHP synthase isozymes; TrpEP290S, anthranilate synthase (component I); PheAT310I, bi-functional chorismate mutase/prephenate dehydratase; PhhAB, phenylalanine 4-monooxygenase; KatG, catalase-peroxidase; PVLB_10925, aromatic-L-amino-acid decarboxylase; PAL, phenylalanine ammonia-lyase.
Figure 4Shake flask cultivations of P. taiwanensis GRC3 Δ8ΔpykA-tap with varying heterologous expression modules. (A) Growth (black lines) and t-cinnamate production (blue lines) by P. taiwanensis GRC3 Δ8ΔpykA-tap attTn7::P14AtPAL- aroG-pheA in MSM containing 20 mM glucose (solid line) or 40 mM of glycerol (dotted line). (B) Growth (black lines) and t-cinnamate production (green lines) by P. taiwanensis GRC3 Δ8ΔpykA-tap attTn7::P14AtPAL in MSM containing 20 mM glucose (solid line) or 40 mM of glycerol (dotted line). Error bars represent the standard error of the mean (n = 3).
Figure 5dO2-stat fed-batch fermentations of t-cinnamate producing strains of P. taiwanensis. Cultivations were performed in MSM, where the initial batch medium contained either glucose or glycerol as sole carbon source and the subsequent feeding solution contained solely the respective carbon source. The top graphs show growth (black lines) and t-cinnamate accumulation (blue lines) during fermentation of P. taiwanensis GRC3 Δ8ΔpykA-tap attTn7::P14AtPAL- aroG-pheA on glucose (A) and glycerol (B). The glycerol figure (B) displays data of a single reactor. The bottom graphs represent growth (black lines) and t-cinnamate accumulation (green lines) during fermentation of P. taiwanensis GRC3 Δ8ΔpykA-tap attTn7::P14AtPAL on glucose (C) and glycerol (D). The error bars represent the standard error (n = 2).
Comparison of t-cinnamate titer, yield, and volumetric productivity of strains P. taiwanensis GRC3 Δ8ΔpykA-tap attTn7::P14gAtPAL- aroGfbr-pheAT310 and GRC3 Δ8ΔpykA-tap attTn7::P14AtPAL in shake flask cultivations and fed-batch fermentations.
| Shake flask glucose | Final titer [mM] | 3.8 ± 0.20 | 3.3 ± 0.07 |
| Yield (% Cmol Cmol−1) | 25.9 ± 0.1 | 22.8 ± 0.5 | |
| Productivity (mM h−1) | 0.10 ± 0.00 | 0.13 ± 0.00 | |
| Shake flask glycerol | Final titer [mM] | 6.3 ± 0.12 | 5.4 ± 0.22 |
| Yield (% Cmol Cmol−1) | 47.5 ± 0.9 | 38.9 ± 1.6 | |
| Productivity (mM h−1) | 0.09 ± 0.01 | 0.11 ± 0.00 | |
| Fed-batch glucose | Final titer [mM] | 17.2 ± 0.3 | 33.2 ± 2.4 |
| Yield (% Cmol Cmol−1) | 11.2 ± 0.6 | 21.4 ± 1.1 | |
| Productivity (mM h−1) | 0.19 ± 0.20 | 0.30 ± 0.02 | |
| Fed-batch glycerol | Final titer [mM] | 19.8 ( | 33.5 ± 2.7 |
| Yield (% Cmol Cmol−1) | 47.8 ( | 36.1 ± 0.08 | |
| Productivity (mM h−1) | 0.13 ( | 0.15 ± 0.00 | |